ORMP insider filings

ORAMED PHARMACEUTICALS INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-13. Screen ORMP transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 14 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Hexter Joshua — COO & CBO3—1 leg · 30,000 sh · $135,3307
Gabay Avraham — Chief Financial Officer3—1 leg · 20,000 sh · $90,2003
KIDRON NADAV — President and CEO, Director2——10
Kidron Miriam — Chief Scientific Officer, Director2——10
Aghion Daniel — Director1——2
Mayer Arie — Director1——2
Reznick Yehuda — Director1——2
Shapiro Benjamin — Director1——2

Recent insider filings — ORAMED PHARMACEUTICALS INC.

FiledFormInsiderReported transactionsSource
2026-11-134Shapiro Benjamin — DirectorGrant/award (A): 72,780 · Grant/award (A): 1,050EDGAR
2026-11-134Reznick Yehuda — DirectorGrant/award (A): 72,780 · Grant/award (A): 2,890EDGAR
2026-11-134Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 357,000 · Grant/award (A): 242,000EDGAR
2026-11-134Gabay Avraham — Chief Financial OfficerGrant/award (A): 357,000 · Grant/award (A): 242,000EDGAR
2026-11-134Hexter Joshua — COO & CBOGrant/award (A): 357,000 · Grant/award (A): 242,000EDGAR
2026-11-134KIDRON NADAV — President and CEO, DirectorGrant/award (A): 629,000 · Grant/award (A): 688,000EDGAR
2026-11-134Aghion Daniel — DirectorGrant/award (A): 72,780 · Grant/award (A): 2,890EDGAR
2026-11-134Mayer Arie — DirectorGrant/award (A): 72,780 · Grant/award (A): 1,470EDGAR
2026-10-024Hexter Joshua — COO & CBOSale (S): 30,000 @ $4.51EDGAR
2026-10-024Gabay Avraham — Chief Financial OfficerSale (S): 20,000 @ $4.51EDGAR
2026-09-254Gabay Avraham — Chief Financial OfficerGrant/award (A): 209,291EDGAR
2026-09-254Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 208,125 · Grant/award (A): 209,291 · Disposition to issuer (D): 104,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 69,999 (derivative) · Disposition to issuer (D): 47,000 (derivative) · +2 moreEDGAR
2026-09-254Hexter Joshua — COO & CBOGrant/award (A): 75,455 · Grant/award (A): 209,291 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 36,000 (derivative)EDGAR
2026-09-254KIDRON NADAV — President and CEO, DirectorGrant/award (A): 349,497 · Grant/award (A): 368,765 · Disposition to issuer (D): 196,500 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Disposition to issuer (D): 49,000 (derivative) · Disposition to issuer (D): 97,000 (derivative) · +2 moreEDGAR
2026-07-024Hexter Joshua — COO & CBOSale (S): 137,000 @ $4.46 · Option exercise (M): 50,000 @ $3.69 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2026-07-024Gabay Avraham — Chief Financial OfficerSale (S): 73,360 @ $4.51EDGAR
2026-03-314KIDRON NADAV — President and CEO, DirectorTax withholding (F): 44,818 @ $3.31EDGAR
2026-03-314Kidron Miriam — Chief Scientific Officer, DirectorTax withholding (F): 435,084 @ $3.31EDGAR
2026-03-184Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 119,558 @ $0EDGAR
2026-03-184KIDRON NADAV — President and CEO, DirectorGrant/award (A): 167,005 @ $0EDGAR
2026-03-184Hexter Joshua — COO & CBOGrant/award (A): 95,889 @ $0EDGAR
2026-03-184Gabay Avraham — Chief Financial OfficerGrant/award (A): 95,889 @ $0EDGAR
2026-03-164KIDRON NADAV — President and CEO, DirectorGift (G): 100,000 @ $0EDGAR
2026-01-294KIDRON NADAV — President and CEO, DirectorOption exercise (M): 109,000 @ $0 · Option exercise (M): 109,000 (derivative) @ $0EDGAR
2026-01-294Kidron Miriam — Chief Scientific Officer, DirectorOption exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0EDGAR
2026-01-294Hexter Joshua — COO & CBOOption exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0EDGAR
2026-01-294Gabay Avraham — Chief Financial OfficerOption exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0EDGAR
2026-01-214Kidron Miriam — Chief Scientific Officer, DirectorGift (G): 86,166 @ $0EDGAR
2026-01-054Reznick Yehuda — DirectorGrant/award (A): 30,000 · Grant/award (A): 6,250EDGAR
2026-01-054KIDRON NADAV — President and CEO, DirectorGrant/award (A): 232,640 @ $0 · Grant/award (A): 327,000 @ $0 · Grant/award (A): 109,000 (derivative) @ $0EDGAR
2026-01-054Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 121,331 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-01-054Hexter Joshua — COO & CBOGrant/award (A): 97,328 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-01-054Shapiro Benjamin — DirectorGrant/award (A): 30,000 · Grant/award (A): 3,500EDGAR
2026-01-054Mayer Arie — DirectorGrant/award (A): 30,000 · Grant/award (A): 4,900EDGAR
2026-01-024Aghion Daniel — DirectorGrant/award (A): 30,000 · Grant/award (A): 6,250EDGAR
2026-01-024Gabay Avraham — Chief Financial OfficerGrant/award (A): 81,216 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-094Mayer Arie — DirectorGrant/award (A): 30,000 · Grant/award (A): 6,975EDGAR
2025-06-094Aghion Daniel — DirectorGrant/award (A): 30,000 · Grant/award (A): 8,371EDGAR
2025-06-094Reznick Yehuda — DirectorGrant/award (A): 30,000 · Grant/award (A): 8,370EDGAR
2025-06-094Sank Leonard — DirectorGrant/award (A): 30,000 · Grant/award (A): 6,510EDGAR
2025-06-094Shapiro Benjamin — DirectorGrant/award (A): 30,000 · Grant/award (A): 4,650EDGAR
2025-02-114Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 74,000 @ $0 · Grant/award (A): 52,000 @ $0 · Grant/award (A): 66,667 @ $0EDGAR
2025-02-114Hexter Joshua — COO & CBOGrant/award (A): 45,000 @ $0 · Grant/award (A): 48,500 @ $0 · Grant/award (A): 33,334 @ $0EDGAR
2025-02-114KIDRON NADAV — President and CEO, DirectorGrant/award (A): 141,000 @ $0 · Grant/award (A): 186,000 @ $0 · Grant/award (A): 100,000 @ $0EDGAR
2025-02-114Gabay Avraham — Chief Financial OfficerGrant/award (A): 34,000 @ $0 · Grant/award (A): 42,000 @ $0EDGAR
2025-01-064Kidron Miriam — Chief Scientific Officer, DirectorGrant/award (A): 207,000EDGAR
2025-01-064KIDRON NADAV — President and CEO, DirectorGrant/award (A): 433,500EDGAR
2025-01-064Gabay Avraham — Chief Financial OfficerGrant/award (A): 188,000EDGAR
2025-01-064Hexter Joshua — COO & CBOGrant/award (A): 194,500EDGAR
2024-11-084Hexter Joshua — COO & CBOGrant/award (A): 30,000EDGAR

Recent 8-K events — ORAMED PHARMACEUTICALS INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K8.01 — Other EventsEDGAR
2026-09-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-308-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-318-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
EDGAR
2026-02-208-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-148-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-318-K8.01 — Other EventsEDGAR
2025-12-318-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-178-K1.01 — Entry into a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ORMP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs